Clinical Trial Update: Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating carbon ion radiotherapy (3 GyE per fraction) for locally recurrent nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Shanghai Proton and Heavy Ion Center | Conditions: Nasopharyngeal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED